A veterinary sedative called medetomidine is increasingly found in New York's illicit fentanyl, linked to deep sedation and dozens of deaths in 2024–25.

Blueroot Health recalled two lots of Vital Nutrients Aller-C after internal testing found undeclared egg, hazelnut and soy. Online orders nationwide, including NY and NJ, may be affected.

About a dozen Bronx cancer survivors rallied outside Gov. Hochul’s NYC office, warning that budget language could narrow Medicaid access to biomarker testing and deepen disparities.

Survivors of last summer’s Harlem Legionnaires outbreak say they still suffer and are organizing a lawsuit after reporting gaps in testing, maintenance and inspections.

New studies and reporting show MS may appear earlier or differently in Latino patients, raising concerns about delayed diagnosis and access to care.

A new iSelect index finds New Jersey and New York among the priciest U.S. states to give birth, with average delivery bills above $31K and concerning maternal‑mortality data. Policy fixes are moving but costs remain high.

Patients and birth workers say NewYork‑Presbyterian’s Alexandra Cohen unit has faced reports of cleanliness, staffing and maintenance problems that clash with its luxury image. The allegations have spread online and raised fresh questions about care at the Upper East Side facility.

Northwell says it will invest roughly $7 million to open an outpatient mental‑health clinic on the Upper East Side tied to the Lenox Hill expansion. The pledge comes amid ongoing neighborhood fights over the hospital’s redevelopment.

NYU gastroenterologist Aasma Shaukat warns that colorectal cancer is rising in younger adults as new American Cancer Society data show cause for concern.

Yeshiva University announced a three‑year dental school in Midtown Manhattan with specialty clinics and an accelerated DDS curriculum as the city faces dentist shortages.

Junebar recalled two Junebar flavors sold in New York after undeclared milk and soy were found in certain batches; check batch codes L1300/L1301 and return affected bars.

A new Value in Health analysis co‑authored by Memorial Sloan Kettering and Turquoise Health finds fuller hospital price disclosure is linked to meaningful declines in commercial oncology prices, with the biggest drops where disclosure is broad and complete.

Parents say Mount Sinai paused pediatric gender-affirming treatment and referred families to private clinics as federal rules loom.